Unusual Site Thrombosis

Rajani, 2009, Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience, Liver Int, 29, 253, 10.1111/j.1478-3231.2008.01838.x Almdal, 1991, Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data, Hepatology, 13, 650, 10.1002/hep.1840130407 Ögren, 2006, Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23 796 consecutive autopsies, World J Gastroenterol, 12, 2115, 10.3748/wjg.v12.i13.2115 Acosta, 2008, Epidemiology, risk and prognostic factors in mesenteric venous thrombosis, Br J Surg, 95, 1245, 10.1002/bjs.6319 Stam, 2005, Thrombosis of the cerebral veins and sinuses, N Engl J Med, 352, 1791, 10.1056/NEJMra042354 Klein, 2000, The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study, Trans Am Ophthalmol Soc, 98, 133 Rogers, 2010, The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia, Ophthalmol, 117, 313, 10.1016/j.ophtha.2009.07.017 Thatipelli, 2010, Survival and recurrence in patients with splanchnic vein thromboses, Clin Gastroenterol Hepatol, 8, 200, 10.1016/j.cgh.2009.09.019 Dentali, 2009, JAK2V617F mutation for the early diagnosis of Ph-negative myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis, Blood, 113, 5617, 10.1182/blood-2008-12-196014 Condat, 2001, Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy, Gastroenterology, 120, 490, 10.1053/gast.2001.21209 Plessier, 2010, Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study, Hepatology, 51, 210, 10.1002/hep.23259 Dentali, 2008, Inherited thrombophilic abnormalities and risk of portal vein thrombosis: a meta-analysis, Thromb Haemost, 99, 675, 10.1160/TH07-08-0526 Squizzato, 2007, A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients, Clin Infect Dis, 44, e13, 10.1086/509641 Hedayati, 2008, Prognostic factors and treatment outcome in mesenteric vein thrombosis, Vasc Endovasc Surg, 42, 217, 10.1177/1538574407312653 Dentali, 2009, Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study, Thromb Haemost, 102, 501, 10.1160/TH08-12-0842 Valla, 2004, Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West, J Gastroenterol Hepatol, 19, S204, 10.1111/j.1440-1746.2004.03642.x De Stefano, 2010, Splanchnic vein thrombosis: clinical presentation, risk factors and tratment, Intern Emerg Med, 6, 487, 10.1007/s11739-010-0413-6 Garcia-Pagan, 2008, TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients, Gastroenterology, 135, 808, 10.1053/j.gastro.2008.05.051 Darwish Murad, 2004, Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome, Hepatology, 39, 500, 10.1002/hep.20064 Sarin, 2006, Consensus on extra-hepatic portal vein obstruction, Liver Int, 26, 512, 10.1111/j.1478-3231.2006.01269.x De Franchis, 2005, Evolving consensus in portal hypertension, J Hepatol, 43, 167, 10.1016/j.jhep.2005.05.009 Amitrano, 2007, Prognostic factors in noncirrhotic patients with splanchnic vein thromboses, Am J Gastroenterol, 102, 2464, 10.1111/j.1572-0241.2007.01477.x Condat, 2000, Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy, Hepatology, 32, 466, 10.1053/jhep.2000.16597 Tripodi, 2010, Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method, Hepatology, 52, 249, 10.1002/hep.23653 Ferro, 2004, Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT), Stroke, 35, 664, 10.1161/01.STR.0000117571.76197.26 Martinelli, 2010, Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis, Circulation, 121, 2740, 10.1161/CIRCULATIONAHA.109.927046 Coutinho, 2009, Cerebral venous and sinus thrombosis in women, Stroke, 40, 2356, 10.1161/STROKEAHA.108.543884 Dentali, 2006, Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis, Blood, 107, 2766, 10.1182/blood-2005-09-3578 Lanska, 2000, Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis, Stroke, 31, 1274, 10.1161/01.STR.31.6.1274 Cantu, 1993, Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases, Stroke, 24, 1880, 10.1161/01.STR.24.12.1880 Bousser, 2007, Cerebral venous thrombosis: an update, Lancet Neurol, 6, 162, 10.1016/S1474-4422(07)70029-7 Dentali, 2006, Natural history of cerebral vein thrombosis: a systematic review, Blood, 108, 1129, 10.1182/blood-2005-12-4795 Stolz, 2004, Influence of recanalization on outcome in dural sinus thrombosis: a prospective study, Stroke, 35, 544, 10.1161/01.STR.0000112972.09096.65 Strupp, 2002, Cerebral venous thrombosis: correlation between recanalization and clinical outcome: a long-term follow-up of 40 patients, J Neurol, 249, 1123, 10.1007/s00415-002-0749-6 Einhaupl, 1991, Heparin treatment in sinus venous thrombosis, Lancet, 338, 597, 10.1016/0140-6736(91)90607-Q de Bruijn, 1999, Randomized, placebo-controlled trial of anticoagulant treatment with low- molecular-weight heparin for cerebral sinus thrombosis, Stroke, 30, 484, 10.1161/01.STR.30.3.484 Stam, 2002, Anticoagulation for cerebral sinus thrombosis, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD002005 Ageno, 2010, Evidence and clinical judgement: treatment of cerebral vein thrombosis, Thromb Haemost, 103, 1109, 10.1160/TH09-12-0827 Dentali, 2010, Safety of thrombolysis in cerebral venous thrombosis, Thromb Haemost, 104, 1055, 10.1160/TH10-05-0311 O'Mahoney, 2008, Retinal vein occlusion and traditional risk factors for atherosclerosis, Arch Ophthalmol, 126, 692, 10.1001/archopht.126.5.692 Hayreh, 2001, Systemic diseases associated with various types of retinal vein occlusion, Am J Ophthalmol, 131, 61, 10.1016/S0002-9394(00)00709-1 Koizumi, 2007, Central retinal vein occlusion case-control study, Am J Ophthalmol, 144, 858, 10.1016/j.ajo.2007.07.036 David, 1988, Epidemiology of retinal vein occlusion and its association with glaucoma and increased intra-ocular pressure, Ophthalmologica, 197, 69, 10.1159/000309923 Janssen, 2005, Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis?, Thromb Haemost, 93, 1021, 10.1160/TH04-11-0768 Rehak, 2008, The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors, Thromb Haemost, 99, 925, 10.1160/TH07-11-0658 Rehak, 2009, Antiphospholipid syndrome and retinal vein occlusion, Ophthalmologe, 106, 427, 10.1007/s00347-008-1811-2 Rehak, 2010, The role of thrombophilia in patients with retinal vein occlusion without systemic risk factors, Can J Ophthalmol, 45, 171, 10.3129/i09-273 1993, Baseline and early natural history report, Arch Ophthalmol, 111, 1087, 10.1001/archopht.1993.01090080083022 Rehak, 2008, Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities, Curr Eye Res, 33, 111, 10.1080/02713680701851902 1997, Natural history and clinical management of central retinal vein occlusion, Arch Ophthalmol, 115, 486, 10.1001/archopht.1997.01100150488006 Michels, 1974, Natural course of temporal retinal branch occlusion, Trans Am Acad Ophthalmol Otolaryngol, 78, 166 McIntosh, 2010, Natural history of central retinal vein occlusion: an evidence-based systematic review, Ophthalmology, 117, 1113, 10.1016/j.ophtha.2010.01.060 Rogers, 2010, Natural history of branch retinal vein occlusion: an evidence-based systematic review, Ophthalmology, 117, 1094, 10.1016/j.ophtha.2010.01.058 Ageno, 2010, Parnaparin versus aspirin in the treatment of retinal vein occlusion, Thromb Res, 125, 137, 10.1016/j.thromres.2009.05.007 Farahvash, 2008, Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid, Can J Ophthalmol, 43, 79, 10.3129/i07-190 Farahvash, 2008, Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial, Arch Iran Med, 11, 418 Lazo-Langner, 2010, Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials, Haematologica, 95, 1587, 10.3324/haematol.2010.023614 Squizzato, 2010, Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action, Thromb Haemost, 103, 271, 10.1160/TH09-09-0626 Kohner, 1974, Streptokinase in the treatment of central retinal vein occlusion, Trans Ophthal Soc UK, 94, 599 Hattenbach, 2009, Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion, Retina, 29, 932, 10.1097/IAE.0b013e3181a3b870 Houtsmuller, 1984, The influence of ticlopidine on the natural course of retinal vein occlusion, Agents Actions Suppl, 15, 219 Martin, 2002, Cardiovascular risk assessment in patients with retinal vein occlusion, Br J Ophthalmol, 86, 774, 10.1136/bjo.86.7.774